Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma

EFE n., altas e., MAZLUMOGLU m. r., AKTAN B., ucuncu h., EREN S., ...Daha Fazla

JOURNAL OF CRANIOFACIAL SURGERY, cilt.27, sa.7, ss.1802-1803, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 7
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1097/scs.0000000000002983
  • Dergi Adı: JOURNAL OF CRANIOFACIAL SURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1802-1803
  • Atatürk Üniversitesi Adresli: Evet

Özet

Though the lymphangioma is a benign neoplasm, it may make an invasion to vital structures by progressively growing. For lymphangioma, which progressed in such a way, surgical treatment has high morbidity and recurrence risk. On these cases, OK-432 is a frequently used sclerotherapy agent. The authors report the result they obtained by the use of single-dose OK-432 on an inoperable pediatric cervical macrocystic lymphangioma case and also their experiences.